beta
Trial Radar AI
One study matched filter criteria
Card View

Randomized Controlled Trial of Home Telemonitoring for Elderly People (Dreaming) 300 Randomized Senior-Focused

Unknown status
Clinical Trial NCT00893685 (Dreaming) is an interventional study for Diabetes Mellitus, Chronic Heart Failure, Chronic Obstructive Pulmonary Disease that is unknown status. It started on May 1, 2009 with plans to enroll 300 participants. Led by Health Information Management, Belgium, it is expected to complete by December 1, 2011. The latest data from ClinicalTrials.gov was last updated on May 8, 2009.
Brief Summary
The DREAMING clinical trial is part of the DREAMING project, which has the objective to demonstrate that the DREAMING platform consisting of integrated health monitoring, alarm handling and videoconferencing services produces clinical benefits to its users and economic benefits to the health authorities. The study evaluates the long-term (30 months) effect of continuous use of the DREAMING subsystems and is testing t...Show More
Detailed Description
Homes of participants are equipped with environmental sensors, motion detection, and with wireless sensors for blood pressure, blood glucose, body weight, blood oxygen saturation, peak expiratory flow and electrocardiogram. Disease related parameters are monitored at least daily and the measured values are transmitted to a central monitoring unit. In case of abnormal values, health alarms are generated and transmitte...Show More
Official Title

Elderly Friendly Alarm Handling and Monitoring (DREAMING)

Conditions
Diabetes MellitusChronic Heart FailureChronic Obstructive Pulmonary Disease
Other Study IDs
  • Dreaming
  • European Commission
  • European Commission
  • ICT support policy program
  • Contract Number 225023
NCT ID Number
Start Date (Actual)
2009-05
Last Update Posted
2009-05-08
Completion Date (Estimated)
2011-12
Enrollment (Estimated)
300
Study Type
Interventional
PHASE
N/A
Status
Unknown status
Keywords
Telemedicine
Primary Purpose
Health Services Research
Design Allocation
Randomized
Interventional Model
Parallel
Masking
None (Open Label)
Arms / Interventions
Participant Group/ArmIntervention/Treatment
ExperimentalHome telemonitoring
Wireless monitors for disease specific clinical parameters.
Homes of participants will be equipped with wireless monitors for blood pressure, blood oxygen, blood glucose, peak expiratory flow, electrocardiogram, body weight. All vital parameters are monitored on a continuous, at least daily basis and obtained values are transmitted to a monitoring centre. Abnormal values are classified for their health risk and health alarms and/or intervention of health professionals is trig...Show More
No InterventionUsual care (control group)
N/A
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Health related quality of life as assessed by the SF-36 questionnaire, at the beginning, at midterm and at the end of the trial period
0, 15, 30 months
Secondary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Time to permanent transfer to elderly homes
Measured at month 30
Total and average length of stay in hospital
Measured at month 30
Number of consultations with general practitioners
Measured at month 30
Number of consultations with medical specialists
Measured at month 30
Number of home visits by nurses
Measured at month 30
Number of ambulance transports
Measured at month 30
Number of accesses to emergency rooms
Measured at month 30
Number of falls
Measured at month 30
Number of femur fractures
Measured at month 30
HbA1c change over time (only for participants with a diagnosis of diabetes)
Measured at month 30
Survival
Measured at month 30
Depression as measured by HADS
Measured at months 0, 15 and 30
Number of hospitalisations
Measured at month 30
Number of permanent transfers to elderly homes
Measured at month 30
Eligibility Criteria

Eligible Ages
Older Adult
Minimum Age
65 Years
Eligible Sexes
All
Accepts Healthy Volunteers
Yes

Inclusion criteria:

  • Diagnosis of chronic heart failure
  • Diagnosis of diabetes mellitus
  • Diagnosis of chronic obstructive pulmonary disease

Only in the case that the number of recruited participants is not sufficient, inclusion criteria can be extended to one or more of the following conditions:

  • History of myocardial infarction
  • History of stroke (brain ischemia or hemorrhage)
  • History of falls within the last two years
  • Hospitalization during the last two years (for every reason)

  • Not willing to participate (e.g non signing informed consent)
  • Inability to use the DREAMING equipment
  • Significant impairment of language comprehension or expression (aphasia)
  • Diagnosis of dementia
  • Completely dependent on others for the activities of daily living
  • Living without access to ISDN or DSL service
Health Information Management, Belgium logoHealth Information Management, Belgium
Study Central Contact
Contact: Reinhard W Prior, M.D., +393341855067, [email protected]
6 Study Locations in 6 Countries
GP Surgery, Heby, 74432, Sweden
Langeland Municipality, Langeland, 5900, Denmark
Pflegwerk Berlin, Mediplus, Berlin, 10439, Germany
East Tallin Central Hospital, Tallinn, 10123, Estonia
Azienda per i Servizi Sanitari ASS N.1, Trieste, 34128, Italy
Servicio Aragones de Salud, Barbastro, 22300, Spain